The International Debate on Generic Medicines of Biological Origin
The debate on generic medicines is not new. What makes it different today is that attacks levelled against biological products are couched in ever more “technical” and abstruse language that confuses even the World Health Organization (WHO).
WHO Advice: Stop using antibiotics in healthy animals to prevent the spread of antibiotic resistance
The Value Added of the United Nations General Assembly High–Level Political Declaration on Antimicrobial Resistance
In September 2016, the United Nations General Assembly (UNGA) in New York held a dedicated meeting to muster strong political commitment for an effective global response to the problem of antimicrobial resistance (AMR). As a result, a High-Level Political Declaration on Antimicrobial Resistance was adopted.
World running out of antibiotics, says WHO in new reports
Growing impetus to making AMR an integral issue in the 2030 Agenda for Sustainable Development
Antibiotic-resistant gonorrhea crisis: new drugs needed
State of discussion on AMR action, two years after the WHA Global Plan
Civil society and South Centre call for urgent actions to tackle AMR and ensure access and new innovation models
Intellectual Property, Public Health and Access to Medicines in International Organizations
This South Centre research paper by Dr. German Velasquez describes and analyses the mandate, programmes, strategies, and activities that different international organizations such as WHO, WTO, WIPO, UNCTAD, UNDP, UNAIDS, the UN Human Rights Council, and the UN Secretary-General’s High Level Panel (UNHLP) on access to medicines have undertaken on the subject of access to medicines, intellectual property, international trade rules and human rights.
South Centre Statement to the 10th NAM Health Ministerial
Below is a statement made by the South Centre’s Deputy Executive Director Vicente Paolo B. Yu III during the meeting of the Ministers of health of the Non-Aligned Movement held in Geneva on 23 May 2017 in conjunction with the World Health Assembly.
Access to Hepatitis C Treatment: A Global Problem
“Viral hepatitis is an international public health challenge, comparable to other major communicable diseases, including HIV, tuberculosis and malaria. Despite the significant burden it places on communities across all global regions, hepatitis has been largely ignored as a health and development priority until recently”. – WHO, Global Health Sector strategy on viral Hepatitis 2016-2021: Towards ending viral hepatitis
Title: Impact of the recommendations of the United Nations Secretary-General’s High-Level Panel on Access to Medicines: Discussion in the context of the 2030 Agenda for Sustainable Development
Date: Wednesday, 24 May 2017, 18:00-19:30
Venue: Room 7, Palais des Nations, Geneva, Switzerland
Organizers: The South Centre, Morocco, Bolivia, India, Uganda, Venezuela, UNSG HLP A2M, PPD
